nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—coronary artery disease—type 2 diabetes mellitus	0.338	1	CtDrD
Acetylsalicylic acid—EDNRA—type 2 diabetes mellitus	0.154	0.749	CbGaD
Acetylsalicylic acid—EDNRA—Irbesartan—type 2 diabetes mellitus	0.0529	0.187	CbGbCtD
Acetylsalicylic acid—PTGS2—type 2 diabetes mellitus	0.0272	0.133	CbGaD
Acetylsalicylic acid—ALB—type 2 diabetes mellitus	0.0243	0.118	CbGaD
Acetylsalicylic acid—SLC22A7—Glyburide—type 2 diabetes mellitus	0.00931	0.0328	CbGbCtD
Acetylsalicylic acid—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.00882	0.0311	CbGbCtD
Acetylsalicylic acid—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.00882	0.0311	CbGbCtD
Acetylsalicylic acid—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.00814	0.0287	CbGbCtD
Acetylsalicylic acid—ALB—Gliclazide—type 2 diabetes mellitus	0.00775	0.0273	CbGbCtD
Acetylsalicylic acid—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.00773	0.0273	CbGbCtD
Acetylsalicylic acid—ALB—Repaglinide—type 2 diabetes mellitus	0.00728	0.0257	CbGbCtD
Acetylsalicylic acid—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00704	0.0248	CbGbCtD
Acetylsalicylic acid—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.00689	0.0243	CbGbCtD
Acetylsalicylic acid—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00668	0.0236	CbGbCtD
Acetylsalicylic acid—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00641	0.0226	CbGbCtD
Acetylsalicylic acid—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00608	0.0214	CbGbCtD
Acetylsalicylic acid—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.00586	0.0207	CbGbCtD
Acetylsalicylic acid—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00563	0.0198	CbGbCtD
Acetylsalicylic acid—ALB—Valsartan—type 2 diabetes mellitus	0.00537	0.0189	CbGbCtD
Acetylsalicylic acid—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00535	0.0188	CbGbCtD
Acetylsalicylic acid—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00509	0.0179	CbGbCtD
Acetylsalicylic acid—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00502	0.0177	CbGbCtD
Acetylsalicylic acid—ALB—Nateglinide—type 2 diabetes mellitus	0.00499	0.0176	CbGbCtD
Acetylsalicylic acid—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00491	0.0173	CbGbCtD
Acetylsalicylic acid—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00477	0.0168	CbGbCtD
Acetylsalicylic acid—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0047	0.0166	CbGbCtD
Acetylsalicylic acid—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00454	0.016	CbGbCtD
Acetylsalicylic acid—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00449	0.0158	CbGbCtD
Acetylsalicylic acid—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00427	0.015	CbGbCtD
Acetylsalicylic acid—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00427	0.015	CbGbCtD
Acetylsalicylic acid—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00418	0.0147	CbGbCtD
Acetylsalicylic acid—SLC22A6—Glyburide—type 2 diabetes mellitus	0.00396	0.014	CbGbCtD
Acetylsalicylic acid—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00394	0.0139	CbGbCtD
Acetylsalicylic acid—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00381	0.0134	CbGbCtD
Acetylsalicylic acid—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0037	0.013	CbGbCtD
Acetylsalicylic acid—SLC22A6—Losartan—type 2 diabetes mellitus	0.00362	0.0128	CbGbCtD
Acetylsalicylic acid—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00355	0.0125	CbGbCtD
Acetylsalicylic acid—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00355	0.0125	CbGbCtD
Acetylsalicylic acid—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00345	0.0121	CbGbCtD
Acetylsalicylic acid—ALB—Glyburide—type 2 diabetes mellitus	0.00337	0.0119	CbGbCtD
Acetylsalicylic acid—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00328	0.0115	CbGbCtD
Acetylsalicylic acid—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00316	0.0112	CbGbCtD
Acetylsalicylic acid—ALB—Losartan—type 2 diabetes mellitus	0.00308	0.0109	CbGbCtD
Acetylsalicylic acid—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00289	0.0102	CbGbCtD
Acetylsalicylic acid—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00269	0.00948	CbGbCtD
Acetylsalicylic acid—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00258	0.00909	CbGbCtD
Acetylsalicylic acid—CYP2C8—Losartan—type 2 diabetes mellitus	0.00238	0.0084	CbGbCtD
Acetylsalicylic acid—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00237	0.00834	CbGbCtD
Acetylsalicylic acid—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00219	0.0077	CbGbCtD
Acetylsalicylic acid—CYP2C19—Losartan—type 2 diabetes mellitus	0.002	0.00705	CbGbCtD
Acetylsalicylic acid—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00182	0.0064	CbGbCtD
Acetylsalicylic acid—ABCB1—Glyburide—type 2 diabetes mellitus	0.00176	0.00622	CbGbCtD
Acetylsalicylic acid—CYP2C9—Losartan—type 2 diabetes mellitus	0.00166	0.00586	CbGbCtD
Acetylsalicylic acid—ABCB1—Losartan—type 2 diabetes mellitus	0.00161	0.00569	CbGbCtD
Acetylsalicylic acid—NFKBIA—nerve—type 2 diabetes mellitus	0.00152	0.0512	CbGeAlD
Acetylsalicylic acid—HSPA5—nerve—type 2 diabetes mellitus	0.00149	0.0501	CbGeAlD
Acetylsalicylic acid—TP53—endothelium—type 2 diabetes mellitus	0.00131	0.0443	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—type 2 diabetes mellitus	0.00129	0.0436	CbGeAlD
Acetylsalicylic acid—TP53—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000894	1	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—islet of Langerhans—type 2 diabetes mellitus	0.000736	0.0248	CbGeAlD
Acetylsalicylic acid—HSPA5—islet of Langerhans—type 2 diabetes mellitus	0.000721	0.0243	CbGeAlD
Acetylsalicylic acid—NFKBIA—retina—type 2 diabetes mellitus	0.000629	0.0212	CbGeAlD
Acetylsalicylic acid—HSPA5—retina—type 2 diabetes mellitus	0.000616	0.0208	CbGeAlD
Acetylsalicylic acid—RPS6KA3—islet of Langerhans—type 2 diabetes mellitus	0.000614	0.0207	CbGeAlD
Acetylsalicylic acid—NFKBIA—nephron tubule—type 2 diabetes mellitus	0.000592	0.02	CbGeAlD
Acetylsalicylic acid—HSPA5—nephron tubule—type 2 diabetes mellitus	0.00058	0.0196	CbGeAlD
Acetylsalicylic acid—PTGS2—leg—type 2 diabetes mellitus	0.000548	0.0185	CbGeAlD
Acetylsalicylic acid—TP53—cardiovascular system—type 2 diabetes mellitus	0.000541	0.0182	CbGeAlD
Acetylsalicylic acid—NFKBIA—cardiovascular system—type 2 diabetes mellitus	0.000532	0.0179	CbGeAlD
Acetylsalicylic acid—TP53—kidney—type 2 diabetes mellitus	0.000529	0.0178	CbGeAlD
Acetylsalicylic acid—TP53—pancreas—type 2 diabetes mellitus	0.000526	0.0177	CbGeAlD
Acetylsalicylic acid—RPS6KA3—retina—type 2 diabetes mellitus	0.000525	0.0177	CbGeAlD
Acetylsalicylic acid—HSPA5—cardiovascular system—type 2 diabetes mellitus	0.000521	0.0176	CbGeAlD
Acetylsalicylic acid—NFKBIA—kidney—type 2 diabetes mellitus	0.000521	0.0175	CbGeAlD
Acetylsalicylic acid—NFKBIA—pancreas—type 2 diabetes mellitus	0.000517	0.0174	CbGeAlD
Acetylsalicylic acid—TP53—cortex of kidney—type 2 diabetes mellitus	0.000515	0.0174	CbGeAlD
Acetylsalicylic acid—HSPA5—kidney—type 2 diabetes mellitus	0.00051	0.0172	CbGeAlD
Acetylsalicylic acid—NFKBIA—cortex of kidney—type 2 diabetes mellitus	0.000507	0.0171	CbGeAlD
Acetylsalicylic acid—HSPA5—pancreas—type 2 diabetes mellitus	0.000506	0.0171	CbGeAlD
Acetylsalicylic acid—HSPA5—cortex of kidney—type 2 diabetes mellitus	0.000497	0.0167	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nephron tubule—type 2 diabetes mellitus	0.000494	0.0167	CbGeAlD
Acetylsalicylic acid—PTGS2—hindlimb—type 2 diabetes mellitus	0.000489	0.0165	CbGeAlD
Acetylsalicylic acid—TP53—adipose tissue—type 2 diabetes mellitus	0.000477	0.0161	CbGeAlD
Acetylsalicylic acid—NFKBIA—adipose tissue—type 2 diabetes mellitus	0.000469	0.0158	CbGeAlD
Acetylsalicylic acid—HSPA5—adipose tissue—type 2 diabetes mellitus	0.00046	0.0155	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cardiovascular system—type 2 diabetes mellitus	0.000444	0.015	CbGeAlD
Acetylsalicylic acid—RPS6KA3—kidney—type 2 diabetes mellitus	0.000434	0.0146	CbGeAlD
Acetylsalicylic acid—RPS6KA3—pancreas—type 2 diabetes mellitus	0.000431	0.0145	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cortex of kidney—type 2 diabetes mellitus	0.000423	0.0143	CbGeAlD
Acetylsalicylic acid—RPS6KA3—adipose tissue—type 2 diabetes mellitus	0.000391	0.0132	CbGeAlD
Acetylsalicylic acid—EDNRA—cortex of kidney—type 2 diabetes mellitus	0.000344	0.0116	CbGeAlD
Acetylsalicylic acid—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000342	0.0115	CbGeAlD
Acetylsalicylic acid—TP53—liver—type 2 diabetes mellitus	0.000334	0.0113	CbGeAlD
Acetylsalicylic acid—NFKBIA—liver—type 2 diabetes mellitus	0.000329	0.0111	CbGeAlD
Acetylsalicylic acid—IKBKB—cardiovascular system—type 2 diabetes mellitus	0.000328	0.011	CbGeAlD
Acetylsalicylic acid—HSPA5—liver—type 2 diabetes mellitus	0.000322	0.0109	CbGeAlD
Acetylsalicylic acid—EDNRA—adipose tissue—type 2 diabetes mellitus	0.000318	0.0107	CbGeAlD
Acetylsalicylic acid—PTGS1—artery—type 2 diabetes mellitus	0.000314	0.0106	CbGeAlD
Acetylsalicylic acid—IKBKB—cortex of kidney—type 2 diabetes mellitus	0.000312	0.0105	CbGeAlD
Acetylsalicylic acid—SLC22A7—kidney—type 2 diabetes mellitus	0.000311	0.0105	CbGeAlD
Acetylsalicylic acid—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.000303	0.0102	CbGeAlD
Acetylsalicylic acid—PTGS2—artery—type 2 diabetes mellitus	0.0003	0.0101	CbGeAlD
Acetylsalicylic acid—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000292	0.00986	CbGeAlD
Acetylsalicylic acid—IKBKB—adipose tissue—type 2 diabetes mellitus	0.000289	0.00974	CbGeAlD
Acetylsalicylic acid—RPS6KA3—liver—type 2 diabetes mellitus	0.000274	0.00925	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—type 2 diabetes mellitus	0.000265	0.00893	CbGeAlD
Acetylsalicylic acid—PTGS2—endothelium—type 2 diabetes mellitus	0.000253	0.00854	CbGeAlD
Acetylsalicylic acid—IKBKB—liver—type 2 diabetes mellitus	0.000203	0.00683	CbGeAlD
Acetylsalicylic acid—SLC22A7—liver—type 2 diabetes mellitus	0.000197	0.00663	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—type 2 diabetes mellitus	0.000177	0.305	CrCbGaD
Acetylsalicylic acid—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000144	0.00486	CbGeAlD
Acetylsalicylic acid—CYP2C8—kidney—type 2 diabetes mellitus	0.000132	0.00443	CbGeAlD
Acetylsalicylic acid—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000119	0.00402	CbGeAlD
Acetylsalicylic acid—ALB—liver—type 2 diabetes mellitus	0.000118	0.00399	CbGeAlD
Acetylsalicylic acid—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000109	0.00367	CbGeAlD
Acetylsalicylic acid—PTGS1—kidney—type 2 diabetes mellitus	0.000107	0.0036	CbGeAlD
Acetylsalicylic acid—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000104	0.00351	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—type 2 diabetes mellitus	0.000103	0.178	CrCbGaD
Acetylsalicylic acid—PTGS2—kidney—type 2 diabetes mellitus	0.000102	0.00344	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—type 2 diabetes mellitus	0.000102	0.175	CrCbGaD
Acetylsalicylic acid—PTGS2—pancreas—type 2 diabetes mellitus	0.000101	0.00341	CbGeAlD
Acetylsalicylic acid—PTGS1—adipose tissue—type 2 diabetes mellitus	9.61e-05	0.00324	CbGeAlD
Acetylsalicylic acid—CYP2C19—liver—type 2 diabetes mellitus	9.52e-05	0.00321	CbGeAlD
Acetylsalicylic acid—PTGS2—adipose tissue—type 2 diabetes mellitus	9.19e-05	0.0031	CbGeAlD
Acetylsalicylic acid—ABCB1—islet of Langerhans—type 2 diabetes mellitus	8.91e-05	0.003	CbGeAlD
Acetylsalicylic acid—CYP2C8—liver—type 2 diabetes mellitus	8.31e-05	0.0028	CbGeAlD
Acetylsalicylic acid—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	8.24e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Convulsion—Glyburide—type 2 diabetes mellitus	8.22e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Pruritus—Rosiglitazone—type 2 diabetes mellitus	8.13e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Glyburide—type 2 diabetes mellitus	8.08e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Urticaria—Glipizide—type 2 diabetes mellitus	7.99e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	7.94e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—type 2 diabetes mellitus	7.9e-05	0.136	CrCbGaD
Acetylsalicylic acid—Anaemia—Gliclazide—type 2 diabetes mellitus	7.87e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	7.86e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Agitation—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Confusional state—Glyburide—type 2 diabetes mellitus	7.81e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Influenza—Ramipril—type 2 diabetes mellitus	7.79e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Asthma—Ramipril—type 2 diabetes mellitus	7.79e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Angioedema—Gliclazide—type 2 diabetes mellitus	7.78e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Sweating—Losartan—type 2 diabetes mellitus	7.77e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	7.74e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Vomiting—Repaglinide—type 2 diabetes mellitus	7.73e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	7.71e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Rash—Repaglinide—type 2 diabetes mellitus	7.67e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Repaglinide—type 2 diabetes mellitus	7.66e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Urticaria—Pioglitazone—type 2 diabetes mellitus	7.66e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Gliclazide—type 2 diabetes mellitus	7.63e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—ABCB1—retina—type 2 diabetes mellitus	7.62e-05	0.00257	CbGeAlD
Acetylsalicylic acid—Shock—Glyburide—type 2 diabetes mellitus	7.62e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Dizziness—Rosiglitazone—type 2 diabetes mellitus	7.6e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Flushing—Metformin—type 2 diabetes mellitus	7.6e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	7.58e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	7.55e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Somnolence—Bromocriptine—type 2 diabetes mellitus	7.53e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	7.49e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	7.49e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Urticaria—Glimepiride—type 2 diabetes mellitus	7.46e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	7.46e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Urticaria—Sitagliptin—type 2 diabetes mellitus	7.44e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Glipizide—type 2 diabetes mellitus	7.41e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—CYP2C9—liver—type 2 diabetes mellitus	7.38e-05	0.00249	CbGeAlD
Acetylsalicylic acid—Convulsion—Gliclazide—type 2 diabetes mellitus	7.38e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Hypertension—Gliclazide—type 2 diabetes mellitus	7.36e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Chest pain—Gliclazide—type 2 diabetes mellitus	7.25e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Gliclazide—type 2 diabetes mellitus	7.25e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Rash—Rosiglitazone—type 2 diabetes mellitus	7.25e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	7.24e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Nausea—Repaglinide—type 2 diabetes mellitus	7.22e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Irbesartan—type 2 diabetes mellitus	7.2e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—ABCB1—nephron tubule—type 2 diabetes mellitus	7.17e-05	0.00242	CbGeAlD
Acetylsalicylic acid—Flushing—Irbesartan—type 2 diabetes mellitus	7.17e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Angioedema—Valsartan—type 2 diabetes mellitus	7.15e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Pruritus—Glipizide—type 2 diabetes mellitus	7.12e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	7.1e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Angioedema—Orlistat—type 2 diabetes mellitus	7.07e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Vertigo—Valsartan—type 2 diabetes mellitus	7.03e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Syncope—Valsartan—type 2 diabetes mellitus	7.02e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Confusional state—Gliclazide—type 2 diabetes mellitus	7.01e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	6.98e-05	0.000996	CcSEcCtD
Acetylsalicylic acid—Vertigo—Orlistat—type 2 diabetes mellitus	6.95e-05	0.000992	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	6.92e-05	0.000987	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Glyburide—type 2 diabetes mellitus	6.9e-05	0.000985	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	6.9e-05	0.000984	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Glipizide—type 2 diabetes mellitus	6.88e-05	0.000983	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Valsartan—type 2 diabetes mellitus	6.88e-05	0.000982	CcSEcCtD
Acetylsalicylic acid—Nausea—Rosiglitazone—type 2 diabetes mellitus	6.83e-05	0.000974	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Glyburide—type 2 diabetes mellitus	6.82e-05	0.000973	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	6.81e-05	0.000972	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Gliclazide—type 2 diabetes mellitus	6.79e-05	0.000969	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Losartan—type 2 diabetes mellitus	6.78e-05	0.000968	CcSEcCtD
Acetylsalicylic acid—Flushing—Losartan—type 2 diabetes mellitus	6.75e-05	0.000963	CcSEcCtD
Acetylsalicylic acid—Urticaria—Bromocriptine—type 2 diabetes mellitus	6.73e-05	0.00096	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	6.72e-05	0.000959	CcSEcCtD
Acetylsalicylic acid—Convulsion—Orlistat—type 2 diabetes mellitus	6.7e-05	0.000956	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Valsartan—type 2 diabetes mellitus	6.66e-05	0.000951	CcSEcCtD
Acetylsalicylic acid—Chest pain—Valsartan—type 2 diabetes mellitus	6.66e-05	0.000951	CcSEcCtD
Acetylsalicylic acid—Sweating—Ramipril—type 2 diabetes mellitus	6.66e-05	0.00095	CcSEcCtD
Acetylsalicylic acid—Dizziness—Glipizide—type 2 diabetes mellitus	6.65e-05	0.00095	CcSEcCtD
Acetylsalicylic acid—Pruritus—Glimepiride—type 2 diabetes mellitus	6.64e-05	0.000948	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	6.59e-05	0.000941	CcSEcCtD
Acetylsalicylic acid—Chest pain—Orlistat—type 2 diabetes mellitus	6.58e-05	0.00094	CcSEcCtD
Acetylsalicylic acid—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.44e-05	0.00217	CbGeAlD
Acetylsalicylic acid—PTGS2—liver—type 2 diabetes mellitus	6.44e-05	0.00217	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	6.42e-05	0.000917	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	6.4e-05	0.000914	CcSEcCtD
Acetylsalicylic acid—Vomiting—Glipizide—type 2 diabetes mellitus	6.4e-05	0.000913	CcSEcCtD
Acetylsalicylic acid—Syncope—Metformin—type 2 diabetes mellitus	6.39e-05	0.000912	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000912	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Glyburide—type 2 diabetes mellitus	6.38e-05	0.000911	CcSEcCtD
Acetylsalicylic acid—Dizziness—Pioglitazone—type 2 diabetes mellitus	6.37e-05	0.00091	CcSEcCtD
Acetylsalicylic acid—Rash—Glipizide—type 2 diabetes mellitus	6.34e-05	0.000905	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—PTGS2—type 2 diabetes mellitus	6.34e-05	0.109	CrCbGaD
Acetylsalicylic acid—Dermatitis—Glipizide—type 2 diabetes mellitus	6.34e-05	0.000905	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	6.31e-05	0.000901	CcSEcCtD
Acetylsalicylic acid—ABCB1—kidney—type 2 diabetes mellitus	6.31e-05	0.00213	CbGeAlD
Acetylsalicylic acid—Shock—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000897	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Metformin—type 2 diabetes mellitus	6.26e-05	0.000894	CcSEcCtD
Acetylsalicylic acid—ABCB1—pancreas—type 2 diabetes mellitus	6.26e-05	0.00211	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	6.25e-05	0.000893	CcSEcCtD
Acetylsalicylic acid—Anaemia—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000887	CcSEcCtD
Acetylsalicylic acid—Dizziness—Glimepiride—type 2 diabetes mellitus	6.21e-05	0.000886	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Gliclazide—type 2 diabetes mellitus	6.2e-05	0.000885	CcSEcCtD
Acetylsalicylic acid—Dizziness—Sitagliptin—type 2 diabetes mellitus	6.19e-05	0.000883	CcSEcCtD
Acetylsalicylic acid—Agitation—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000882	CcSEcCtD
Acetylsalicylic acid—Somnolence—Gliclazide—type 2 diabetes mellitus	6.18e-05	0.000882	CcSEcCtD
Acetylsalicylic acid—Hypertension—Metformin—type 2 diabetes mellitus	6.15e-05	0.000878	CcSEcCtD
Acetylsalicylic acid—Urticaria—Glyburide—type 2 diabetes mellitus	6.15e-05	0.000878	CcSEcCtD
Acetylsalicylic acid—Angioedema—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000877	CcSEcCtD
Acetylsalicylic acid—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.14e-05	0.00207	CbGeAlD
Acetylsalicylic acid—Dyspepsia—Gliclazide—type 2 diabetes mellitus	6.12e-05	0.000874	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	6.1e-05	0.000871	CcSEcCtD
Acetylsalicylic acid—Chest pain—Metformin—type 2 diabetes mellitus	6.07e-05	0.000866	CcSEcCtD
Acetylsalicylic acid—Vertigo—Irbesartan—type 2 diabetes mellitus	6.04e-05	0.000863	CcSEcCtD
Acetylsalicylic acid—Syncope—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000861	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000859	CcSEcCtD
Acetylsalicylic acid—Nausea—Glipizide—type 2 diabetes mellitus	5.98e-05	0.000853	CcSEcCtD
Acetylsalicylic acid—Vomiting—Glimepiride—type 2 diabetes mellitus	5.97e-05	0.000852	CcSEcCtD
Acetylsalicylic acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.95e-05	0.000849	CcSEcCtD
Acetylsalicylic acid—Rash—Glimepiride—type 2 diabetes mellitus	5.92e-05	0.000845	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.91e-05	0.000844	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000844	CcSEcCtD
Acetylsalicylic acid—Rash—Sitagliptin—type 2 diabetes mellitus	5.9e-05	0.000842	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.9e-05	0.000842	CcSEcCtD
Acetylsalicylic acid—Anaemia—Losartan—type 2 diabetes mellitus	5.85e-05	0.000835	CcSEcCtD
Acetylsalicylic acid—Agitation—Losartan—type 2 diabetes mellitus	5.82e-05	0.00083	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Ramipril—type 2 diabetes mellitus	5.81e-05	0.00083	CcSEcCtD
Acetylsalicylic acid—Hypertension—Irbesartan—type 2 diabetes mellitus	5.81e-05	0.000829	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.8e-05	0.000827	CcSEcCtD
Acetylsalicylic acid—Flushing—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000826	CcSEcCtD
Acetylsalicylic acid—Angioedema—Losartan—type 2 diabetes mellitus	5.78e-05	0.000826	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.73e-05	0.000818	CcSEcCtD
Acetylsalicylic acid—Chest pain—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000817	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000817	CcSEcCtD
Acetylsalicylic acid—Shock—Metformin—type 2 diabetes mellitus	5.72e-05	0.000817	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.7e-05	0.000814	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.7e-05	0.000813	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.7e-05	0.000813	CcSEcCtD
Acetylsalicylic acid—Vertigo—Losartan—type 2 diabetes mellitus	5.69e-05	0.000812	CcSEcCtD
Acetylsalicylic acid—ABCB1—adipose tissue—type 2 diabetes mellitus	5.68e-05	0.00192	CbGeAlD
Acetylsalicylic acid—Somnolence—Valsartan—type 2 diabetes mellitus	5.68e-05	0.000811	CcSEcCtD
Acetylsalicylic acid—Syncope—Losartan—type 2 diabetes mellitus	5.68e-05	0.00081	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Losartan—type 2 diabetes mellitus	5.67e-05	0.000809	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—ALB—type 2 diabetes mellitus	5.65e-05	0.0973	CrCbGaD
Acetylsalicylic acid—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.62e-05	0.000803	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.62e-05	0.000803	CcSEcCtD
Acetylsalicylic acid—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.6e-05	0.000799	CcSEcCtD
Acetylsalicylic acid—Nausea—Glimepiride—type 2 diabetes mellitus	5.58e-05	0.000796	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.56e-05	0.000794	CcSEcCtD
Acetylsalicylic acid—Nausea—Sitagliptin—type 2 diabetes mellitus	5.56e-05	0.000793	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.56e-05	0.000793	CcSEcCtD
Acetylsalicylic acid—Urticaria—Gliclazide—type 2 diabetes mellitus	5.52e-05	0.000788	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000784	CcSEcCtD
Acetylsalicylic acid—Pruritus—Glyburide—type 2 diabetes mellitus	5.48e-05	0.000782	CcSEcCtD
Acetylsalicylic acid—Shock—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000771	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Losartan—type 2 diabetes mellitus	5.39e-05	0.000769	CcSEcCtD
Acetylsalicylic acid—Chest pain—Losartan—type 2 diabetes mellitus	5.39e-05	0.000769	CcSEcCtD
Acetylsalicylic acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.39e-05	0.000769	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.38e-05	0.000767	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000765	CcSEcCtD
Acetylsalicylic acid—Rash—Bromocriptine—type 2 diabetes mellitus	5.34e-05	0.000762	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.34e-05	0.000762	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000757	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.3e-05	0.000756	CcSEcCtD
Acetylsalicylic acid—Confusional state—Losartan—type 2 diabetes mellitus	5.21e-05	0.000744	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.2e-05	0.000742	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Metformin—type 2 diabetes mellitus	5.19e-05	0.00074	CcSEcCtD
Acetylsalicylic acid—Somnolence—Metformin—type 2 diabetes mellitus	5.17e-05	0.000738	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.17e-05	0.000737	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.12e-05	0.000731	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Metformin—type 2 diabetes mellitus	5.12e-05	0.000731	CcSEcCtD
Acetylsalicylic acid—Shock—Losartan—type 2 diabetes mellitus	5.08e-05	0.000725	CcSEcCtD
Acetylsalicylic acid—Urticaria—Valsartan—type 2 diabetes mellitus	5.07e-05	0.000724	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.06e-05	0.000722	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Losartan—type 2 diabetes mellitus	5.04e-05	0.00072	CcSEcCtD
Acetylsalicylic acid—Nausea—Bromocriptine—type 2 diabetes mellitus	5.03e-05	0.000718	CcSEcCtD
Acetylsalicylic acid—Urticaria—Orlistat—type 2 diabetes mellitus	5.01e-05	0.000716	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.99e-05	0.000713	CcSEcCtD
Acetylsalicylic acid—Agitation—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000712	CcSEcCtD
Acetylsalicylic acid—Angioedema—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000708	CcSEcCtD
Acetylsalicylic acid—Vomiting—Glyburide—type 2 diabetes mellitus	4.92e-05	0.000703	CcSEcCtD
Acetylsalicylic acid—Pruritus—Gliclazide—type 2 diabetes mellitus	4.92e-05	0.000702	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000699	CcSEcCtD
Acetylsalicylic acid—Rash—Glyburide—type 2 diabetes mellitus	4.88e-05	0.000697	CcSEcCtD
Acetylsalicylic acid—Somnolence—Irbesartan—type 2 diabetes mellitus	4.88e-05	0.000697	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Glyburide—type 2 diabetes mellitus	4.88e-05	0.000696	CcSEcCtD
Acetylsalicylic acid—Vertigo—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000696	CcSEcCtD
Acetylsalicylic acid—Syncope—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000695	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000693	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.00069	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.79e-05	0.000684	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000681	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.76e-05	0.000679	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000672	CcSEcCtD
Acetylsalicylic acid—Convulsion—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000671	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000664	CcSEcCtD
Acetylsalicylic acid—Urticaria—Metformin—type 2 diabetes mellitus	4.62e-05	0.00066	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Ramipril—type 2 diabetes mellitus	4.62e-05	0.00066	CcSEcCtD
Acetylsalicylic acid—Chest pain—Ramipril—type 2 diabetes mellitus	4.62e-05	0.00066	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Losartan—type 2 diabetes mellitus	4.61e-05	0.000657	CcSEcCtD
Acetylsalicylic acid—Nausea—Glyburide—type 2 diabetes mellitus	4.6e-05	0.000656	CcSEcCtD
Acetylsalicylic acid—Dizziness—Gliclazide—type 2 diabetes mellitus	4.6e-05	0.000656	CcSEcCtD
Acetylsalicylic acid—Somnolence—Losartan—type 2 diabetes mellitus	4.59e-05	0.000656	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Losartan—type 2 diabetes mellitus	4.55e-05	0.000649	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.52e-05	0.000646	CcSEcCtD
Acetylsalicylic acid—Pruritus—Valsartan—type 2 diabetes mellitus	4.52e-05	0.000645	CcSEcCtD
Acetylsalicylic acid—Confusional state—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000638	CcSEcCtD
Acetylsalicylic acid—Pruritus—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000637	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000632	CcSEcCtD
Acetylsalicylic acid—Vomiting—Gliclazide—type 2 diabetes mellitus	4.42e-05	0.000631	CcSEcCtD
Acetylsalicylic acid—Rash—Gliclazide—type 2 diabetes mellitus	4.38e-05	0.000626	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.38e-05	0.000625	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.37e-05	0.000624	CcSEcCtD
Acetylsalicylic acid—Urticaria—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Shock—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.34e-05	0.000619	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000617	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000616	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000611	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.26e-05	0.000608	CcSEcCtD
Acetylsalicylic acid—Dizziness—Valsartan—type 2 diabetes mellitus	4.22e-05	0.000603	CcSEcCtD
Acetylsalicylic acid—Dizziness—Orlistat—type 2 diabetes mellitus	4.17e-05	0.000596	CcSEcCtD
Acetylsalicylic acid—Nausea—Gliclazide—type 2 diabetes mellitus	4.13e-05	0.000589	CcSEcCtD
Acetylsalicylic acid—Pruritus—Metformin—type 2 diabetes mellitus	4.12e-05	0.000587	CcSEcCtD
Acetylsalicylic acid—Urticaria—Losartan—type 2 diabetes mellitus	4.1e-05	0.000586	CcSEcCtD
Acetylsalicylic acid—Vomiting—Valsartan—type 2 diabetes mellitus	4.06e-05	0.00058	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.000577	CcSEcCtD
Acetylsalicylic acid—Rash—Valsartan—type 2 diabetes mellitus	4.03e-05	0.000575	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Valsartan—type 2 diabetes mellitus	4.02e-05	0.000574	CcSEcCtD
Acetylsalicylic acid—Vomiting—Orlistat—type 2 diabetes mellitus	4.01e-05	0.000573	CcSEcCtD
Acetylsalicylic acid—ABCB1—liver—type 2 diabetes mellitus	3.99e-05	0.00134	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Metformin—type 2 diabetes mellitus	3.98e-05	0.000568	CcSEcCtD
Acetylsalicylic acid—Rash—Orlistat—type 2 diabetes mellitus	3.98e-05	0.000568	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Orlistat—type 2 diabetes mellitus	3.98e-05	0.000568	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000564	CcSEcCtD
Acetylsalicylic acid—Somnolence—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000562	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000557	CcSEcCtD
Acetylsalicylic acid—Pruritus—Irbesartan—type 2 diabetes mellitus	3.88e-05	0.000554	CcSEcCtD
Acetylsalicylic acid—Dizziness—Metformin—type 2 diabetes mellitus	3.85e-05	0.000549	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.81e-05	0.000543	CcSEcCtD
Acetylsalicylic acid—Nausea—Valsartan—type 2 diabetes mellitus	3.79e-05	0.000542	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000536	CcSEcCtD
Acetylsalicylic acid—Nausea—Orlistat—type 2 diabetes mellitus	3.75e-05	0.000535	CcSEcCtD
Acetylsalicylic acid—Vomiting—Metformin—type 2 diabetes mellitus	3.7e-05	0.000528	CcSEcCtD
Acetylsalicylic acid—Rash—Metformin—type 2 diabetes mellitus	3.67e-05	0.000524	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Metformin—type 2 diabetes mellitus	3.66e-05	0.000523	CcSEcCtD
Acetylsalicylic acid—Pruritus—Losartan—type 2 diabetes mellitus	3.66e-05	0.000522	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Dizziness—Irbesartan—type 2 diabetes mellitus	3.63e-05	0.000518	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Losartan—type 2 diabetes mellitus	3.53e-05	0.000505	CcSEcCtD
Acetylsalicylic acid—Urticaria—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000502	CcSEcCtD
Acetylsalicylic acid—Vomiting—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000498	CcSEcCtD
Acetylsalicylic acid—Rash—Irbesartan—type 2 diabetes mellitus	3.46e-05	0.000494	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.46e-05	0.000494	CcSEcCtD
Acetylsalicylic acid—Nausea—Metformin—type 2 diabetes mellitus	3.46e-05	0.000493	CcSEcCtD
Acetylsalicylic acid—Dizziness—Losartan—type 2 diabetes mellitus	3.42e-05	0.000488	CcSEcCtD
Acetylsalicylic acid—Vomiting—Losartan—type 2 diabetes mellitus	3.28e-05	0.000469	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000466	CcSEcCtD
Acetylsalicylic acid—Nausea—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000465	CcSEcCtD
Acetylsalicylic acid—Rash—Losartan—type 2 diabetes mellitus	3.26e-05	0.000465	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Losartan—type 2 diabetes mellitus	3.25e-05	0.000465	CcSEcCtD
Acetylsalicylic acid—Pruritus—Ramipril—type 2 diabetes mellitus	3.13e-05	0.000447	CcSEcCtD
Acetylsalicylic acid—Nausea—Losartan—type 2 diabetes mellitus	3.07e-05	0.000438	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000433	CcSEcCtD
Acetylsalicylic acid—Dizziness—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000418	CcSEcCtD
Acetylsalicylic acid—Vomiting—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000402	CcSEcCtD
Acetylsalicylic acid—Rash—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000399	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000398	CcSEcCtD
Acetylsalicylic acid—Nausea—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000376	CcSEcCtD
Acetylsalicylic acid—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.03e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.03e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.03e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.03e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	1.03e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.03e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.03e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.03e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.03e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.03e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.02e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.02e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.02e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.02e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.02e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.01e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.01e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.01e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.01e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	9.98e-07	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.96e-07	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CALM1—type 2 diabetes mellitus	9.89e-07	1.38e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOE—type 2 diabetes mellitus	9.85e-07	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	9.85e-07	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.78e-07	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.77e-07	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOA1—type 2 diabetes mellitus	9.74e-07	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NFKB1—type 2 diabetes mellitus	9.72e-07	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—type 2 diabetes mellitus	9.66e-07	1.35e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	9.64e-07	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	9.61e-07	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.61e-07	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	9.61e-07	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	9.58e-07	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	9.58e-07	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	9.58e-07	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	9.5e-07	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	9.5e-07	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.42e-07	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	9.41e-07	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.38e-07	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	9.35e-07	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	9.32e-07	1.3e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.28e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.28e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—type 2 diabetes mellitus	9.28e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	9.27e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	9.24e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.22e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.19e-07	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS2—type 2 diabetes mellitus	9.18e-07	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SRC—type 2 diabetes mellitus	9.13e-07	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	9.12e-07	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	9.11e-07	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	9.11e-07	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	9.06e-07	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SRC—type 2 diabetes mellitus	9.05e-07	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.05e-07	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—INS—type 2 diabetes mellitus	9.02e-07	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	8.89e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.89e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	8.89e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—INS—type 2 diabetes mellitus	8.88e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.88e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—type 2 diabetes mellitus	8.87e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	8.86e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	8.8e-07	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.8e-07	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IRS1—type 2 diabetes mellitus	8.79e-07	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—type 2 diabetes mellitus	8.77e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	8.76e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	8.76e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.75e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GNB3—type 2 diabetes mellitus	8.75e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.73e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.72e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	8.71e-07	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	8.7e-07	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	8.67e-07	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	8.67e-07	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	8.64e-07	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAT—type 2 diabetes mellitus	8.59e-07	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	8.45e-07	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	8.42e-07	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—INS—type 2 diabetes mellitus	8.42e-07	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.41e-07	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	8.39e-07	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOB—type 2 diabetes mellitus	8.34e-07	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	8.31e-07	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	8.31e-07	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.29e-07	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	8.28e-07	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	8.25e-07	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.18e-07	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	8.16e-07	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	8.16e-07	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	8.16e-07	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	8.14e-07	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT2—type 2 diabetes mellitus	8.14e-07	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	8.12e-07	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.09e-07	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	8.01e-07	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—LPL—type 2 diabetes mellitus	7.97e-07	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—type 2 diabetes mellitus	7.94e-07	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—type 2 diabetes mellitus	7.93e-07	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.93e-07	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.91e-07	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.91e-07	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.85e-07	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	7.85e-07	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	7.84e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	7.82e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	7.82e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	7.8e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.79e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	7.79e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GPX1—type 2 diabetes mellitus	7.77e-07	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	7.73e-07	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	7.71e-07	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	7.67e-07	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.67e-07	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	7.63e-07	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	7.61e-07	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CD36—type 2 diabetes mellitus	7.57e-07	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.53e-07	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	7.52e-07	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	7.49e-07	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	7.47e-07	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RELA—type 2 diabetes mellitus	7.45e-07	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	7.38e-07	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS3—type 2 diabetes mellitus	7.38e-07	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.31e-07	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.31e-07	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	7.31e-07	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	7.28e-07	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	7.21e-07	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	7.19e-07	1e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	7.17e-07	1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	7.16e-07	9.99e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.16e-07	9.99e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	7.15e-07	9.98e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	7.13e-07	9.94e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	7.12e-07	9.94e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	7.11e-07	9.92e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	7.08e-07	9.87e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—INS—type 2 diabetes mellitus	7.05e-07	9.84e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARA—type 2 diabetes mellitus	7.04e-07	9.82e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	7.03e-07	9.81e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	7e-07	9.77e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.98e-07	9.74e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	6.98e-07	9.73e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	6.85e-07	9.56e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.83e-07	9.53e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	6.83e-07	9.53e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AGT—type 2 diabetes mellitus	6.81e-07	9.51e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.81e-07	9.5e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	6.79e-07	9.48e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	6.74e-07	9.4e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.72e-07	9.37e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	6.72e-07	9.37e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	6.71e-07	9.36e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CALM1—type 2 diabetes mellitus	6.7e-07	9.35e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOE—type 2 diabetes mellitus	6.68e-07	9.31e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	6.64e-07	9.27e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	6.64e-07	9.26e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.63e-07	9.25e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOA1—type 2 diabetes mellitus	6.6e-07	9.21e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.55e-07	9.14e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	6.52e-07	9.1e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	6.46e-07	9.02e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	6.44e-07	8.98e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	6.38e-07	8.9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	6.36e-07	8.87e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.35e-07	8.86e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	6.32e-07	8.81e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	6.28e-07	8.77e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.28e-07	8.76e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	6.2e-07	8.64e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	6.18e-07	8.63e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.18e-07	8.63e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	6.16e-07	8.6e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	6.12e-07	8.53e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	6.12e-07	8.53e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—type 2 diabetes mellitus	6.1e-07	8.51e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	6.01e-07	8.39e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	5.99e-07	8.36e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.97e-07	8.33e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	5.93e-07	8.27e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.87e-07	8.19e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	5.87e-07	8.19e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SRC—type 2 diabetes mellitus	5.85e-07	8.17e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.85e-07	8.16e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	5.85e-07	8.16e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARG—type 2 diabetes mellitus	5.82e-07	8.11e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.78e-07	8.07e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	5.76e-07	8.03e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	5.74e-07	8e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—INS—type 2 diabetes mellitus	5.7e-07	7.96e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.7e-07	7.95e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	5.67e-07	7.91e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—type 2 diabetes mellitus	5.63e-07	7.85e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	5.58e-07	7.78e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	5.48e-07	7.65e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	5.47e-07	7.62e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SRC—type 2 diabetes mellitus	5.46e-07	7.62e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	5.4e-07	7.54e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	5.26e-07	7.34e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.23e-07	7.3e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	5.22e-07	7.28e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.13e-07	7.16e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	5.12e-07	7.14e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	5.1e-07	7.11e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	5.03e-07	7.02e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	5.03e-07	7.02e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NOS3—type 2 diabetes mellitus	5e-07	6.98e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	5e-07	6.98e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—INS—type 2 diabetes mellitus	5e-07	6.97e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	4.88e-07	6.81e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—type 2 diabetes mellitus	4.79e-07	6.68e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	4.76e-07	6.64e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	4.69e-07	6.55e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	4.67e-07	6.51e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	4.6e-07	6.42e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.58e-07	6.39e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	4.57e-07	6.38e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	4.49e-07	6.26e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	4.49e-07	6.26e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.38e-07	6.11e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.38e-07	6.11e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	4.28e-07	5.97e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	4.11e-07	5.73e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.09e-07	5.71e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.09e-07	5.71e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.01e-07	5.59e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—type 2 diabetes mellitus	3.94e-07	5.5e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	3.74e-07	5.22e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—type 2 diabetes mellitus	3.68e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.64e-07	5.07e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	3.58e-07	4.99e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—type 2 diabetes mellitus	3.39e-07	4.73e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	2.84e-07	3.96e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.31e-07	3.23e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.3e-07	3.21e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.06e-07	2.88e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.01e-07	2.81e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.88e-07	2.63e-06	CbGpPWpGaD
